You searched for "Retrobulbar"
Microperimetry of subretinal drusenoid deposits
1 February 2014
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
Subretinal drusenoid deposits (SDD), originally termed ‘reticular pseudo-drusen’, have recently been identified by histology and optical coherence tomography (OCT) as aggregations located in the subretinal rather than the sub retinal pigment epithelium (RPE) space. These deposits affect the amount of...
Adjuvant radiotherapy in orbital malignancy
This is a retrospective review of high dose volumetric modulated arc radiotherapy (VMAT) for adjuvant treatment of patients with orbital malignancy who had already undergone local excision or exenteration. VMAT differs from conventional external beam radiotherapy in that it is...Correlation between peak intraocular pressure following water drinking test and pulsed methylprednisolone therapy
1 December 2013
| Bheemanagouda Patil
|
EYE - Glaucoma
Steroids have long been known to cause increased intraocular pressures (IOP) in susceptible patients. Intravenous methylprednisolone is used to treat many rheumatological conditions and one of the risks is raised intraocular pressure. It would be useful to find patients at...
Early structural and functional retinal changes in intermittent exotropia
28 February 2025
| Fiona Rowe (Prof)
|
EYE - Paediatrics
This study aimed to evaluate and compare spectral domain optical coherence tomography (SD OCT) and electrophysiological measures in patients with intermittent exotropia and healthy controls, to outline changes in retinal and optic nerve structure and function. This was a cross-sectional...
Twenty-four hour IOP patterns in patients with thyroid eye disease (OO/GL)
Elevated IOP in patients with thyroid eye disease (TED) can be caused by restriction and compression of the globe by enlarged extraocular muscles, elevated episcleral venous pressure and increased mucopolysaccharide deposition in the trabecular meshwork. Although previous studies have investigated...Feb/Mar 2015 Quiz 1
1 February 2015
| Shweta Kaushik, Eleni Nikita
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A 79-year-old male presented to the ophthalmic emergency department with a three week history of left eye pain. He also reported visual deterioration in the left eye over the same period. He suffered from degenerative myopia, with his spectacle prescription...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
The approach to angle-closure glaucoma
1 October 2016
| Kaivon Pakzad-Vaezi
|
EYE - Glaucoma
Further to my last article in Eye News (print issue) describing the diagnostic approaches to various clinical scenarios in glaucoma, the approach to angle-closure glaucoma (ACG), a situation terrifying for patient and registrar alike, will be discussed. Please refer to...
Type 3 CNV and anti-VEGF
1 February 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The purpose of the study was to determine the differences between aflibercept and ranibizumab in terms of their therapeutic efficacy in the treatment of Type 3 neovascularisation. The authors highlight that the dominant mechanism for Type 3 neovascularisation development is...
Atrophy and anti-VEGF
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The aim of this study was to investigate treatment factors, along with ocular and systemic factors for their association with macular atrophy (MA) incidence in eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF aflibercept or ranibizumab according to...